EBIT: Income before interest and taxes.
Quest Diagnostics Incorporated (DGX) had EBIT of $399.00M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$2.90B |
|
$252.00M |
|
$1.95B |
|
$942.00M |
|
$2.50B |
|
$399.00M |
|
$-65.00M |
|
$334.00M |
|
$334.00M |
|
$260.00M |
|
$264.00M |
|
$264.00M |
|
$260.00M |
|
|
EBIT |
$399.00M |
-- |
|
110.00M |
|
112.00M |
|
$2.27 |
|
$2.24 |
|
| Balance Sheet Financials | |
$2.57B |
|
$2.19B |
|
$14.11B |
|
$16.67B |
|
$2.18B |
|
$5.16B |
|
$6.83B |
|
$9.01B |
|
$7.67B |
|
$-3.17B |
|
$7.67B |
|
111.00M |
|
| Cash Flow Statement Financials | |
$278.00M |
|
$-152.00M |
|
$-152.00M |
|
$420.00M |
|
$393.00M |
|
$-27.00M |
|
$20.00M |
|
$-95.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|